melatonin has been researched along with pyrimidinones in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cervetto, L; Demontis, GC; Longoni, B; Macchia, B; Macchia, M; Minutolo, F; Orlandini, E; Ortore, G; Papi, C; Sbrana, A | 1 |
| Jeong, JK; Park, SY | 1 |
2 other study(ies) available for melatonin and pyrimidinones
| Article | Year |
|---|---|
New N-n-propyl-substituted 3-aryl- and 3-cyclohexylpiperidines as partial agonists at the D4 dopamine receptor.
Topics: Animals; Binding, Competitive; Corpus Striatum; Crystallography, X-Ray; Dopamine Agonists; Guanine Nucleotides; Guinea Pigs; In Vitro Techniques; Male; Melatonin; Piperidines; Purine Nucleosides; Pyrimidinones; Pyrroles; Radioligand Assay; Receptors, Dopamine D2; Receptors, Dopamine D4; Retina; Structure-Activity Relationship | 2003 |
HIF-1α-induced β-catenin activation prevents prion-mediated neurotoxicity.
Topics: Apoptosis; beta Catenin; Bridged Bicyclo Compounds, Heterocyclic; Cell Hypoxia; Cell Line, Tumor; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; In Situ Nick-End Labeling; Melatonin; Neurons; Peptide Fragments; Prion Diseases; Prions; Pyrimidinones; Up-Regulation; Wnt Signaling Pathway | 2013 |